SCHEMBL20617394

SCHEMBL20617394

N#Cc1cc(-c2cc(-n3c4ccccc4c4ccc5c6ccccc6oc5c43)c(C#N)cc2-n2c3ccccc3c3ccc4c5ccccc5oc4c32)cc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRG P48443 1/20 0.31
▸ XDH P47989 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22564219 0.94 PDPK1 (0.32) PDPK1RXRARXRGXDH
SCHEMBL21414218 0.92 KDM4E (0.33) —
SCHEMBL20617399 0.89 KDM4E (0.32) PDPK1RXRARXRGXDH
SCHEMBL22564557 0.87 RXRA (0.33) PDPK1RXRARXRGXDH
SCHEMBL21738622 0.86 CYP1A2 (0.30) PDPK1
SCHEMBL20617098 0.86 RXRA (0.35) PDPK1RXRARXRGXDH
SCHEMBL21546474 0.86 PGR (0.35) —
SCHEMBL22564518 0.85 RXRA (0.30) RXRARXRG
SCHEMBL22156783 0.85 KDM4E (0.31) —
SCHEMBL20617401 0.84 RXRA (0.36) PDPK1RXRARXRGXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021473-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-06-01 — — US disclosed
US-20200399256-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-24 — — US disclosed
EP-3642302-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 — — EP disclosed
WO-2019001838-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021473-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OCIAD2 PDPK1 4315/4885RXRA 3552/4885RXRG 3138/4885
US-20200399256-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 PDPK1 4178/4885RXRA 3876/4885RXRG 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback